
- /
- Supported exchanges
- / US
- / PRPH.NASDAQ
ProPhase Labs Inc (PRPH NASDAQ) stock market data APIs
ProPhase Labs Inc Financial Data Overview
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get ProPhase Labs Inc data using free add-ons & libraries
Get ProPhase Labs Inc Fundamental Data
ProPhase Labs Inc Fundamental data includes:
- Net Revenue: 12 753 K
- EBITDA: -27 879 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-03-13
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ProPhase Labs Inc News

ProPhase Labs to Present at the Investor Summit Virtual on March 11
GARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and consumer products company, toda...


SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ProPhase Labs, Inc. (NASDAQ: PRPH) and Encourages Investors to Contact the Firm
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”) on behalf of the company’s investors. Since...

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023
Company sees significant momentum in Pharmaloz, Nebula Genomics and ProPhase BioPharma Pharmaloz Manufacturing plans on track to increase capacity from $10 million to over $75 million in 2024 Indic...

INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into ProPhase Labs, Inc.; Urges ProPhase Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”) on behalf of the Company’s investors...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.